Ayako Ojima

Empagliflozin, an Inhibitor of Sodium-Glucose Cotransporter 2 Exerts Anti-Inflammatory and Antifibrotic Effects on Experimental Diabetic Nephropathy Partly by Suppressing AGEs-Receptor Axis

Ayako Ojima, Takanori Matsui, Yoshinori Nishino et al. · Hormone and Metabolic Research · 2015 · 221 citations · Full text

Medicine, Nephrology, Pharmacology +17

Glucagon-Like Peptide-1 Receptor Agonist Inhibits Asymmetric Dimethylarginine Generation in the Kidney of Streptozotocin-Induced Diabetic Rats by Blocking Advanced Glycation End Product–Induced Protein Arginine Methyltranferase-1 Expression

Ayako Ojima, Yuji Ishibashi, Takanori Matsui et al. · American Journal Of Pathology · 2012 · 154 citations · Full text

Medicine, Endocrinology, Pharmacology +12

Sulforaphane reduces advanced glycation end products (AGEs)-induced inflammation in endothelial cells and rat aorta

Takanori Matsui, Nobutaka Nakamura, Ayako Ojima et al. · Nutrition Metabolism and Cardiovascular Diseases · 2016 · 71 citations

Life Sciences, Biochemistry, Pharmacology +17

Glucose-dependent Insulinotropic Polypeptide (GIP) Inhibits Signaling Pathways of Advanced Glycation End Products (AGEs) in Endothelial Cells via its Antioxidative Properties

Ayako Ojima, Takanori Matsui, Sayaka Maeda et al. · Hormone and Metabolic Research · 2012 · 58 citations

Medicine, Endocrinology, Pharmacology +16

Dipeptidyl peptidase-4 deficiency protects against experimental diabetic nephropathy partly by blocking the advanced glycation end products-receptor axis

Takanori Matsui, Sae Nakashima, Yuri Nishino et al. · Laboratory Investigation · 2015 · 52 citations · Full text

Medicine, Endocrinology, Pharmacology +12